Clinical Trials Logo

Clinical Trial Summary

This study evaluates the effect of pretreatment with a multivitamin supplement with probiotics (Seidivid Ferty4®) on oocyte retrieval in normo-responder patients undergoing controlled ovarian hyperstimulation (COH) for oocyte donation, considering both the total number of oocytes retrieved and the number of mature oocytes retrieved, that is, in metaphase II (MII).


Clinical Trial Description

Patients will be recruited on the day they are going to start the egg donation program. The patient will start taking the study treatment (multivitamin supplement with probiotics or placebo) immediately after inclusion and will call the site to initiate the oocyte donation protocol approximately 30 days after enrollment. Throughout the COH period of the protocol the patient will continue taking the study supplement (or placebo), without interruption until the day of the GnRH-agonist trigger. The administration of the agonist will be as a single dose, 36 hours before follicular puncture for the retrieval of mature eggs. Then, the retrieved oocytes will be denuded and examined by light microscopy to assess their quality. The evaluation will carried out by two different embryologists, blinded to the study protocol. ;


Study Design


Related Conditions & MeSH terms

  • Reproductive Techniques, Assisted

NCT number NCT05473039
Study type Interventional
Source SEID S.A.
Contact Ana Gavilan
Phone +34938445730
Email agavilan@lab-seid.com
Status Recruiting
Phase N/A
Start date July 11, 2022
Completion date December 28, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05442125 - First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization N/A
Withdrawn NCT00767611 - Molecular Markers of Human Sperm Function N/A
Completed NCT04549649 - The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response N/A
Completed NCT02567552 - Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone Phase 4
Completed NCT02457481 - An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro N/A
Completed NCT00518141 - Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART) N/A
Terminated NCT01071200 - Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle Phase 3
Recruiting NCT02516462 - In Vitro Maturation of Human Eggs N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT02381821 - Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success N/A
Recruiting NCT02625519 - Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) Phase 4
Active, not recruiting NCT02625532 - Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial) N/A
Completed NCT04458454 - "Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"
Active, not recruiting NCT03901170 - Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle? Phase 4